CompletedNot Applicable

Balloon Pump Assisted Coronary Intervention Study

United Kingdom301 participantsStarted 2005-12

Plain-language summary

This study will test the hypothesis that elective use of the Intra-Aortic Balloon Pump (IABP) in patients undergoing high-risk Percutaneous Coronary Intervention (PCI) will reduce the rate of in-hospital major adverse cardiac and cerebrovascular events compared to patients who are managed without planned insertion of IABP.

Who can participate

Age range

18 Years

Sex

ALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * impaired left ventricular function (Ejection Fraction \< 30%) * large area of myocardium at risk (BCIS-1 Myocardial Jeopardy Score ≥ 8/12) Exclusion Criteria: * cardiogenic shock * acute STEMI within previous 48 hours * complications of recent AMI (including ventricular septal defect, severe mitral regurgitation, intractable ventricular arrhythmias) * contraindications to IABP use (including significant iliac or femoral arterial disease and more than mild aortic regurgitation)

Questions worth asking your doctor

Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.

1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?

Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.

Questions for the trial coordinator

The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.

1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?

A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.

What they're measuring

Major Adverse Cardiac and Cerebrovascular Events

Timeframe: Hospital discharge or 28 days following PCI, whichever occurs sooner

Trial details

NCT IDNCT00910481

SponsorBritish Cardiovascular Intervention Society

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2011-01

Results submitted2021-02-06

View on ClinicalTrials.gov More Coronary Artery Disease trials